Loading...
Target Audience: U.S. primary care clinicians
The ACIP has released its 2018 immunization recommendations for adults (age, ≥19). This year, little has changed, but the ACIP does recommend a new protocol for zoster vaccination. .
Citing the impressive premarketing efficacy of the new recombinant zoster vaccine (RZV; brand name, Shingrix), the ACIP now recommends that all immunocompetent adults older than 50 receive two doses of RZV, whether or not they have ever had chickenpox or shingles. This recommendation applies to adults who already have received the live zoster vaccine …